FTI
82
-2
XYL
41
-8
PPL
62
5
NDAQ
73
-2
CAT
70
-9
PSX
39
-3
MCHP
49
-5
HAL
55
-5
MTCH
57
-2
AEP
59
-2
NFLX
37
2
ABT
41
3
EQIX
50
-3
VFC
76
-3
RF
74
-2
AA
67
-5
ED
39
3
FDX
53
-2
IP
31
-6
DRI
53
-3
FTI
82
-2
XYL
41
-8
PPL
62
5
NDAQ
73
-2
CAT
70
-9
PSX
39
-3
MCHP
49
-5
HAL
55
-5
MTCH
57
-2
AEP
59
-2
NFLX
37
2
ABT
41
3
EQIX
50
-3
VFC
76
-3
RF
74
-2
AA
67
-5
ED
39
3
FDX
53
-2
IP
31
-6
DRI
53
-3
Financhill
Back

Palantir Technologies, Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Buy
60

PLTR
Palantir Technologies, Inc.

Last Price:
$185.69
Seasonality Move:
4.54%
Sell
48

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$36.36
Seasonality Move:
6.21%
Buy
60
Palantir Technologies, Inc. (PLTR) is a Buy

Is Palantir Technologies, Inc. a Buy, Sell or Hold?

  • The current Palantir Technologies, Inc. [PLTR] share price is $183.57. The Score for PLTR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • PLTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $36.23. The Score for RARE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PLTR Stock Price Chart

What is Palantir Technologies, Inc.'s stock price today?

  • The Palantir Technologies, Inc. share price today is $183.57
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLTR is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $36.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.

PLTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.93 Buy
Relative Strength Index (14 RSI): 56.34 Buy
Chaikin Money Flow: 14120739 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (164.2 - 184.9) Buy
Bollinger Bands (100): (161.68 - 186.36) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.99 Buy
Relative Strength Index (14 RSI): 61.17 Buy
Chaikin Money Flow: -31475 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.18 - 35.78) Buy
Bollinger Bands (100): (28.77 - 33.95) Buy

PLTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 182.26 Buy
20-day SMA: 172.25 Buy
50-day SMA: 179.46 Buy
200-day SMA: 144.41 Buy
8-day EMA: 181.64 Buy
20-day EMA: 177.86 Buy
50-day EMA: 176.51 Buy
200-day EMA: 146.81 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.32 Sell
20-day SMA: 34.36 Buy
50-day SMA: 33.41 Buy
200-day SMA: 33.75 Buy
8-day EMA: 35.88 Buy
20-day EMA: 34.85 Buy
50-day EMA: 33.54 Buy
200-day EMA: 34.8 Buy

Palantir Technologies, Inc. Earnings Growth & PLTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and an increase next year of $0.27 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Palantir Technologies, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):